Delivery Order SPE2DB20D1109-SPE2DB23FP66V
- Not listed
- This federal contract award, valued at $3,645.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,152,217 units of modafinil 200 mg tablets, a prescription medication used to treat conditions such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness. This is a firm fixed-price delivery order contract with an ultimate completion...
- This federal contract award, valued at $11,338.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of modafinil 100 mg tablets, a prescription medication used to treat sleep disorders. The award is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $11,344.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for modafinil 100 mg tablets, a medication used to treat conditions such as sleep disorders. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $7,052.77, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Modafinil 100 mg tablets, a medication commonly used to treat sleep disorders and certain types of fatigue. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Modafinil 100 mg tablets, a medication commonly used to treat sleep disorders. The contract has a ceiling value of $4,028.48 and is a Firm Fixed Price Delivery Order, with a completion date of July 11, 2025. The contract is not set-aside and is open to full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,327.36 firm fixed-price delivery order is for the supply of modafinil 100 mg tablets, a prescription medication used to treat sleep disorders. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,785.70 firm fixed-price delivery order contract is for the delivery of MODAFINIL 200 MG TABLET 30S, a medication commonly used to treat conditions such as narcolepsy, sleep apnea, and shift work sleep disorder. The contract does not have a set-aside designation, indicating open competition. It is associated...
- This federal contract award, valued at $4,251.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of modafinil 100 mg tablets, a medication used to treat conditions such as narcolepsy. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program and is open to...
- This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,237.93 firm fixed price delivery order is for the supply of Modafinil 100 mg tablets, a medication used to treat conditions such as sleep disorders. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,196.18 firm fixed-price contract is for the delivery of modafinil 200 mg tablets, a medication used to treat conditions like sleep disorders. The contract has an ultimate completion date of September 12, 2024. AmerisourceBergen holds a separate $999,999,999 IDC with the DLA Troop Support Medical that serves...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP66VDelivery Order
This federal contract award, valued at $6,714.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Modafinil 200 mg tablets, a medication used to treat conditions such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of August 4, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. The contract award did not specify the use of any set-aside requirements, indicating open competition. This contract award is part of the broader efforts by the DLA and other federal agencies to ensure the reliable supply of essential pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/3/23 |